The Journal of Neuroscience, November 28, 2007, 27(48):13357-13365; doi:10.1523/JNEUROSCI.2718-07.2007
Previous Article
Neurobiology of Disease
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Jenna C. Carroll,1,2
Emily R. Rosario,1,2
Lilly Chang,3
Frank Z. Stanczyk,3
Salvatore Oddo,4
Frank M. LaFerla,4 and
Christian J. Pike2
1Neuroscience Graduate Program, 2Davis School of Gerontology, 3Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California 90089, and 4Department of Neurobiology and Behavior, University of California, Irvine, Irvine, California 92697
Correspondence should be addressed to Christian J. Pike, Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089-0191. Email: cjpike{at}usc.edu
Estrogen depletion in postmenopausal women is a significant risk factor for the development of Alzheimer's disease (AD), and estrogen-based hormone therapy may reduce this risk. However, the effects of progesterone both alone and in combination with estrogen on AD neuropathology remain unknown. In this study, we used the triple transgenic mouse model of AD (3xTg-AD) to investigate the individual and combined effects of estrogen and progesterone on β-amyloid (Aβ) accumulation, tau hyperphosphorylation, and hippocampal-dependent behavioral impairments. In gonadally intact female 3xTg-AD mice, AD-like neuropathology was apparent by 3 months of age and progressively increased through age 12 months, a time course that was paralleled by behavioral impairment. Ovariectomy-induced depletion of sex steroid hormones in adult female 3xTg-AD mice significantly increased Aβ accumulation and worsened memory performance. Treatment of ovariectomized 3xTg-AD mice with estrogen, but not progesterone, prevented these effects. When estrogen and progesterone were administered in combination, progesterone blocked the beneficial effect of estrogen on Aβ accumulation but not on behavioral performance. Interestingly, progesterone significantly reduced tau hyperphosphorylation when administered both alone and in combination with estrogen. These results demonstrate that estrogen and progesterone independently and interactively regulate AD-like neuropathology and suggest that an optimized hormone therapy may be useful in reducing the risk of AD in postmenopausal women.
Key words: estrogen; progesterone; Alzheimer's disease; β-amyloid; tau; Y-maze
Received June 15, 2007;
revised Sept. 27, 2007;
accepted Oct. 5, 2007.
Correspondence should be addressed to Christian J. Pike, Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089-0191. Email: cjpike{at}usc.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2007 27: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
I. Torres-Aleman
Mouse Models of Alzheimer's Dementia: Current Concepts and New Trends
Endocrinology,
December 1, 2008;
149(12):
5952 - 5957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Carroll and C. J. Pike
Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
Endocrinology,
May 1, 2008;
149(5):
2607 - 2611.
[Abstract]
[Full Text]
[PDF]
|
 |
|